Devika Gupta is an accomplished executive with extensive experience in global market access and pricing strategies within the pharmaceuticals industry. Currently serving as Executive Director for Merck, Gupta leads the Immunology & Infectious Disease access team, overseeing strategies that contributed to over $5 billion in revenue in 2023. Prior to this role, Gupta spent over 12 years at Pfizer, holding various leadership positions including Senior Director of Global Market Access & Health Economics Outcomes Research for Pain and Director of Global Market Access for both Pain Launch and Neuroscience Pipeline. Gupta's earlier experience includes consulting with Campbell Alliance and roles in brand marketing at Johnson & Johnson Lifescan and Applied Materials. Gupta holds an MBA from the Kellogg School of Management at Northwestern University and a B.S. in Chemical Engineering from the Massachusetts Institute of Technology.